Skip to Main Content

Paper Details

Development of highly stable and de-immunized versions of recombinant alpha interferon: Promising candidates for the treatment of chronic and emerging viral diseases.
Clin Immunol
5
2021
Author NameAffiliation
William D MartinInc.
Anne S De GrootInc., USA Institute for Immunology and Informatics, University of Rhode Island
  • 1 - 2

Datasets

Release 1.2